report News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

report

Global patient portals market to reach $8.38b by 2030

Thanks to collaborations between new entrants and major software vendors.

Medical device firms eye sustainability amidst regulatory changes

Regulatory shifts may lead to temporary device shortages in the short term.

India’s diagnostic imaging market to exceed $7b by 2033

Thanks to rising healthcare expenditure and a greater demand for accessible solutions.

Medical alert systems market to double by 2032

Thanks to product performance innovations and AI integration.

Global central nervous system market to surpass $80b in 2025

It is the fifth-fastest growing therapy area for the year.

Japan’s 10-year fund to boost pharmaceutical landscape

The country’s ageing population is driving demand for innovative treatments.

Ramkhamhaeng Hospital’s associate profits to recover in FY25: report

However, its profitability is unlikely to reach FY23 levels.

Jordan’s pharmaceutical exports to hit $1.4b by 2029

Thanks to robust infrastructure and sustained demand for high-quality products.

Japan’s medical device market to be valued at $42.9b by 2029

It is projected to surpass Germany to become the third-largest market globally.

China’s neurosurgical robotics market eyes 10% CAGR growth until 2036

The country accounted for 30% of APAC's robotic surgical systems market.

Orthopaedic robot prices to drop 30% in five years: report

Thanks to increased market competition, tech advancements, and economies of scale.

Saudi Arabia’s pharmaceutical market to hit $16.7b by 2029

Thanks to rising investments and increased international collaboration.

Medical composites market to reach $845m by 2030

By end-user type, hospitals are expected to account for the highest demand.

South Korea, China lead degrader-antibody conjugate development: report

Companies from these countries collectively account for 19 out of 28 assets worldwide.

Liposuction surgery devices market to reach $5.24b by 2033

Key growth drivers include improvements in minimally invasive technologies.

Blood cancers lead in CAR-T therapy development: report

Currently, 13 CAR-T treatments have received regulatory approval.